Ongoing Debate About Models for Artificial Pancreas Systems and In Silico Studies.
作者信息
Forlenza Gregory P
机构信息
Barbara Davis Center, University of Colorado Denver , Denver, Colorado.
出版信息
Diabetes Technol Ther. 2018 Mar;20(3):174-176. doi: 10.1089/dia.2018.0038.
Abstract
摘要
相似文献
1
Ongoing Debate About Models for Artificial Pancreas Systems and In Silico Studies.
Diabetes Technol Ther. 2018 Mar;20(3):174-176. doi: 10.1089/dia.2018.0038.
2
[The artificial pancreas. When mathematical equations resolve problems].
Perspect Infirm. 2013 Sep-Oct;10(4):58-9.
3
The artificial pancreas: current status and future prospects in the management of diabetes.
Ann N Y Acad Sci. 2014 Apr;1311:102-23. doi: 10.1111/nyas.12431.
4
Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes.
Drugs. 2019 Jul;79(10):1089-1101. doi: 10.1007/s40265-019-01149-2.
5
Artificial pancreas may soon be a reality.
JAMA. 2009 Apr 15;301(15):1525-7. doi: 10.1001/jama.2009.478.
6
An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
Ther Deliv. 2015;6(5):609-19. doi: 10.4155/tde.15.12.
7
Use of an artificial pancreas at diabetes camps.
Arch Dis Child. 2013 Jul;98(7):514. doi: 10.1136/archdischild-2013-304450.
8
Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes.
J Diabetes Sci Technol. 2015 Jul;9(4):932-3. doi: 10.1177/1932296815580162. Epub 2015 Apr 7.
9
[Technological innovations in the treatment of type 1 diabetes in pediatrics].
Soins Pediatr Pueric. 2016 Jan-Feb(288):38-40. doi: 10.1016/j.spp.2015.11.013.
10
Importance of Artificial Pancreas Standard Nomenclature.
Diabetes Technol Ther. 2017 Jun;19(6):323. doi: 10.1089/dia.2017.0169.
本文引用的文献
1
Best Use of Models to Advance the Artificial Pancreas.
Diabetes Technol Ther. 2018 Mar;20(3):171-173. doi: 10.1089/dia.2017.0420. Epub 2018 Feb 15.
2
Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A and Hypoglycemia.
Diabetes Care. 2017 Dec;40(12):1719-1726. doi: 10.2337/dc17-1188. Epub 2017 Oct 13.
3
The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration.
Pediatr Diabetes. 2018 Feb;19(1):14-17. doi: 10.1111/pedi.12535. Epub 2017 Jun 27.
4
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.
Lancet Diabetes Endocrinol. 2017 Jul;5(7):501-512. doi: 10.1016/S2213-8587(17)30167-5. Epub 2017 May 19.
5
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Diabetes Technol Ther. 2017 Mar;19(3):155-163. doi: 10.1089/dia.2016.0421. Epub 2017 Jan 30.
6
Response to Comment on Pinsker et al. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas. Diabetes Care 2016;39:1135-1142.
Diabetes Care. 2017 Jan;40(1):e4-e5. doi: 10.2337/dci16-0038.
7
Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset-Applications to the pediatric diabetes population.
Pediatr Diabetes. 2017 Nov;18(7):622-628. doi: 10.1111/pedi.12474. Epub 2016 Nov 23.
8
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
JAMA. 2016 Oct 4;316(13):1407-1408. doi: 10.1001/jama.2016.11708.
9
Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.
Diabetes Care. 2016 Jul;39(7):1135-42. doi: 10.2337/dc15-2344. Epub 2016 Jun 11.
10
One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator.
IEEE Trans Biomed Eng. 2016 Nov;63(11):2416-2424. doi: 10.1109/TBME.2016.2535241. Epub 2016 Feb 26.
Zotero 插件